Literature DB >> 33617238

Liver Injury Caused by Green Tea Extract in PD-1-/- Mice: An Impaired Immune Tolerance Model for Idiosyncratic Drug-Induced Liver Injury.

Tiffany Cho1, Xijin Wang1, Karen Yeung2, Yanshan Cao1, Jack Uetrecht1.   

Abstract

Idiosyncratic drug-induced liver injury (IDILI) is an idiosyncratic drug reaction that is specific to an individual and can lead to liver failure and even death. The mechanism of IDILI remains poorly understood, but most IDILI appears to be immune-mediated. We have developed the first validated animal model by using a PD-1-/- mouse model in combination with anti-CTLA-4 to block immune checkpoints and impair immune tolerance. Treatment of these mice with drugs that cause IDILI in humans led to delayed-onset liver injury with characteristics similar to IDILI in humans. The current study investigates the effects of green tea extract, a weight-loss dietary supplement that has been reported to cause IDILI in humans. Green tea extracts contain a highly variable content of catechins including (-)-epigallocatechin gallate, the major catechin in green tea formulations. If the liver injury caused by green tea extract in humans is immune-mediated, it may occur in our impaired immune tolerance model. Female PD-1-/- mice treated with anti-CTLA-4 antibody and green tea extract (500 mg/kg), a dose that is considered a no-observed-adverse-effect level for liver in rodents, produced a delayed onset increase in serum alanine transaminase levels and an increase in hepatic CD8+ T cells. In contrast, the response in male PD-1-/- mice was less pronounced, and there was no evidence of liver injury in wild-type mice. These findings are consistent with the hypothesis that the IDILI caused by green tea extract is immune-mediated and is similar to IDILI caused by medications that are associated with IDILI.

Entities:  

Year:  2021        PMID: 33617238     DOI: 10.1021/acs.chemrestox.0c00485

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  5 in total

Review 1.  Idiosyncratic Drug Reactions: A 35-Year Chemical Research in Toxicology Perspective.

Authors:  Jack Uetrecht
Journal:  Chem Res Toxicol       Date:  2022-06-10       Impact factor: 3.973

Review 2.  Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology.

Authors:  Julian Hercun; Catherine Vincent; Marc Bilodeau; Pascal Lapierre
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.

Authors:  Alessio Gerussi; Ambra Natalini; Fabrizio Antonangeli; Clara Mancuso; Elisa Agostinetto; Donatella Barisani; Francesca Di Rosa; Raul Andrade; Pietro Invernizzi
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 4.  Mechanisms of immune checkpoint inhibitor-mediated liver injury.

Authors:  Layla Shojaie; Myra Ali; Andrea Iorga; Lily Dara
Journal:  Acta Pharm Sin B       Date:  2021-10-16       Impact factor: 11.413

5.  Epigallocatechin gallate ameliorates tetrahydrochloride-induced liver toxicity in rats via inhibition of TGFβ / p-ERK/p-Smad1/2 signaling, antioxidant, anti-inflammatory activity.

Authors:  Gomaa Mostafa-Hedeab; Manal Ewaiss Hassan; Taher F Halawa; Farooq Ahmed Wani
Journal:  Saudi Pharm J       Date:  2022-06-27       Impact factor: 4.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.